Extracellular Vesicles: A New Frontier in Liquid Biopsy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 52
Special Issue Editors
Interests: tumor biomarker; liquid biopsy; extracellular vesicle; cancer immunotherapy
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) have emerged as a transformative component of liquid biopsy, offering unprecedented opportunities for noninvasive cancer diagnosis, prognosis, and therapeutic monitoring, as well as the noncancerous disease like Alzheimer’s disease. EVs encapsulate a diverse array of biomolecules—including proteins, nucleic acids, and metabolites—that reflect the physiological and pathological state of their cell of origin. Recent advances in high-throughput profiling, nanotechnology, and bioinformatics have greatly enhanced our ability to characterize EVs with high sensitivity and specificity, establishing their value as dynamic biomarkers across a wide spectrum of cancers and other diseases. This Special Issue, “Extracellular Vesicles: A New Frontier in Liquid Biopsy”, aims to highlight cutting-edge research on the biology, methodology, and clinical applications of EVs. We welcome submissions that focus on novel EV detection platforms, multi-omics approaches, EV-based biomarkers for early detection and minimal residual disease monitoring, as well as their integration into precision oncology and therapeutic decision making. Both original research and comprehensive reviews are encouraged, with the goal of accelerating translational efforts and fostering collaboration between basic scientists, clinicians, and industry leaders to realize the full potential of EVs in clinical practice.
Dr. Chen Zhao
Dr. You-Ren Ji
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles (EVs)
- liquid biopsy
- circulating biomarkers
- exosome
- nanomedicine
- translational oncology
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
